Circadia Health
London
About Circadia Health
Circadia improves clinical outcomes by using an FDA-approved truly contactless patient monitoring system to detect problems early. The technology measures a patient's respiratory rate from up to 8 feet away, with nothing on the bed or body required. Clinicians use this data to forecast medical events such as congestive heart failure, COPD exacerbations, pneumonia, sepsis, urinary tract infections, and falls several hours or days in advance. To provide personalized, predictive risk alerts 24/7, a team of virtual nurses reviews device data and analyzes trends in the patient's electronic health record.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $10K – $50K
- Total funding: $410.0K
- Funding stage: Early Stage Venture
- Last round: Series A (Aug 2021)
- Website: circadia.health
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Medical Device, Predictive Analytics
Social Profiles
Canonical: https://fsome.com/organization/circadia-health-68912 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.